Abstract
Endomyocardial fibrosis (EMF) is a disease of unknown etiology characterized by progressive fibrosis and obliteration of the right ventricular (RV) or left ventricular (LV) cavities and often associated with atrioventricular valve incompetence. Patients with EMF have a poor prognosis. Surgical treatment usually results in clinical and hemodynamic improvement. 1–6 In this study we present pre- and postoperative clinical and noninvasive follow-up in 15 consecutive patients with EMF.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
